Mini-pill approved by FDA.
D000569:Americas; D001777:Blood Coagulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D009656:North America; D009938:Organizations; D045167:Progesterone Congeners; D013923:Thromboembolism; D014481:United States; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D045167:Progesterone Congeners
Americas; Blood Coagulation Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Methods--pharmacodynamics; Contraceptive Methods--side effects; Developed Countries; Diseases; Embolism; Family Planning; Government Agencies; North America; Northern America; Oral Contraceptives, Low-dose; Oral Contraceptives--pharmacodynamics; Oral Contraceptives--side effects; Organizations; Progestins, Low-dose; Thromboembolism; United States; Use-effectiveness; Vascular Diseases